Figure 2

![Figure 2: Prevalence and diagnostic criteria for mild cognitive impairment and mild dementia, contextualizing the therapeutic opportunity for Ginkgo biloba extract EGb 761.]()

> Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." *Pharmaceuticals (Basel, Switzerland)*, 2021. PMID: [33915701](https://pubmed.ncbi.nlm.nih.gov/33915701/)

<figure>
  <img src="" alt="Prevalence and diagnostic criteria for mild cognitive impairment and mild dementia, contextualizing the therapeutic opportunity for Ginkgo biloba extract EGb 761." />
  <figcaption>Figure 2. Prevalence and diagnostic criteria for mild cognitive impairment and mild dementia, contextualizing the therapeutic opportunity for Ginkgo biloba extract EGb 761.<br>  Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33915701/">33915701</a></figcaption>
</figure>